Polymorphism in IgA nephropathy

Nephrology

Volumn 3, Issue 1, 1997, Pages 63-66

  Liu, Zhi Hong ^a,b   Li, Lei Shi ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b JINLING HOSPITAL   (China)

Author keywords

angiotensin II type 1 receptor gene; angiotensin converting enzyme gene; immune deposits; interleukin 1 receptor antagonist gene

Indexed keywords

ANGIOTENSIN RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

CLINICAL FEATURE; CONFERENCE PAPER; DISEASE COURSE; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; IMMUNE COMPLEX DEPOSITION; IMMUNOGLOBULIN A NEPHROPATHY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030945311     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.1997.tb00191.x     Document Type: Conference Paper

References (32)

1. Emancipator SN. IgA nephropathy: Morphologic expression and pathogenesis. Am. J. Kidney Dis. 1994; 23: 451-62.
2. Galla JH. IgA nephropathy. Kidney Int. 1995; 47: 377-87.
3. Clarkson AR, Woodroffe AJ, Bannister KM et al. The syndrome of IgA nephropathy. Clin. Nephrol. 1984; 21: 7-14.
4. Wyatt RJ, Julian BA. Activation of complement in IgA nephropathy. Am. J. Kidney Dis. 1988; 12: 437-42.
5. Hebert LA, Cosio FG, Birmingham DJ. The role of complement system in renal injury. Semin. Nephrol. 1992; 12: 408-12.
6. Torbohm I, Schonermark M, Winger AM et al. C5b-8 and C5b-9 modulate the collagen release of human glomerular epithelial cells. Kidney Int. 1990; 37: 1098-1104.
7. Alexopoulos E, Papaghianni A, Papadimitriou M. The pathogenetic significance of C5b-9 in IgA nephropathy. Nephrol. Dial. Transplant. 1995; 10: 1166-72.
8. Wolf U. The genetic contribution to the phenotype. Hum. Genet. 1995; 95: 127-48.
9. Wyatt RJ, Julian BA, Woodfood SY et al. C4A deficiency and poor prognosis in patients with IgA nephropathy. Clin. Nephrol. 1991; 35: 1-5.
10. Nagasawa R, Mastumura O, Marayama N et al. Influence of the T-cell receptor β-chain gene on the progression of IgA nephropathy in Japanese patients. Nephron 1995; 71: 350-1.
11. Schena FP. Immunogenetic aspects of primary IgA nephropathy. Kidney Int. 1995; 48: 1998-2013.
12. Freedman BI, Spray BJ, Heise ER. HLA association in IgA nephropathy and focal and segmental glomerulosclerosis. Am. J. Kidney Dis. 1994; 23: 352-7.
13. Cambien F, Poirier O, Lecerf L et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-4.
14. Tirer L, Rigat B, Visvikis S et al. Evidence from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am. J. Hum. Genet. 1992; 51: 197-205.
15. Tiret L, Bonnardeaux A, Poirier O et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphism on risk of myocardial infarction. Lancet 1994; 344: 910-13.
16. Doria A, Warram JH, Krolewski AS. Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I-converting enzyme gene. Diabetes 1994; 43: 690-5.
17. Mizuiri S, Hemmi H, Inoue A et al. Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes ellitus. Nephron 1995; 70: 455-9.
18. Harden P, Geddes C, Rowe PA et al. Polymorphism in angiotensin-converting enzyme gene and progression of IgA nephropathy. Lancet 1995; 3456: 1540-2.
19. Hunley TE, Julian BA, Phillips JA et al. Angiotensin-converting enzyme gene polymorphism: Potential silencer motif and impact on progression of IgA nephropathy. Kidney Int. 1996; 49: 571-7.
20. Schmidt S, Stier E, Hartung R et al. No association of converting enzyme insertion/deletion polymorphism with immunoglobulin A glomerulonephritis. Am. J. Kidney Dis. 1995; 26: 727-31.
21. Schunder H, Hense HW, Hoemer SR et al. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N. Engl. J. Med. 1994; 330: 1634-7.
22. Lewis EJ, Hunsicker LG, Baun RP. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N. Engl. J. Med. 1993; 329: 1456-62.
23. Remuzzi A, Perticucci E, Ruggenenti P et al. Angiotensin-converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy. Kidney Int. 1991; 39: 1267-73.
24. Cattran DC, Greenwood C, Ritchie S. Long-term benefit of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: A comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. Am. J. Kidney Dis. 1994; 23: 247-54.
25. Maschio G, Cagnoli L, Claroni F et al. ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: A multicentre, randomized, placebo-controlled study. Nephrol. Dial. Transplant. 1994; 9: 265-9.
26. Yoshida H, Mitarai T, Kawamura T et al. Role of the deletion polymorphism of the angiotensin-converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J. Clin. Invest. 1995; 96: 2161-9.
27. Lan HY, Nikolic-Paterson DJ, Zarama M et al. Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist. Kidney Int. 1993; 43: 479-85.
28. Tarlow JK, Blakemore AIF, Lennard A et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable number of an 86-bp tandem repeat. Human Genet. 1993; 91: 403-4.
29. Clay FE, Tarlow JK, Blakemore AIF et al. Interleukin-1 receptor antagonist gene polymorphism associated with lichen sclerosis. Human Genet. 1994; 94: 407-10.
30. Mansfield JC, Holden H, Tarlow JK et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokin interleukin-1 receptor antagonist. Gastroenterology 1994; 106: 637-42.
31. Blakemore AIF, Tarlow JK, Cork MJ et al. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosis. Arthritis Rheum. 1994; 37: 1380-5.
32. Blakemore AIF, Cox A, Gonzalez AM et al. Interleukin-1 receptor antagonist allele (IL-IRN*2) associated with nephropathy in diabetes mellitus. Hum. Genet. 1996; 97: 369-74.